ADRB2 inhibition suppresses cancer immune evasion by regulating tumor SOX10-PD-L1 axis and T cell function
Background Chronic stress is known to promote cancer progression, in part by modulating immune responses through the β2-adrenergic receptor (ADRB2). Inhibiting ADRB2 with β-blockers has demonstrated potential in boosting the effectiveness of immune checkpoint inhibitors across a spectrum of cancers,...
Saved in:
| Main Authors: | Yang Wang, Wei Zhang, Yu Zhang, Ling Chen, Shiyu Wang, Kun Song, Feng Yu, Jing Ouyang, Shan Cao, Cong Peng, Dongbo Liu, Yingying Dai, Wenwu Pei, Ziyang Hong, Weihua Huang, Yijing He, Panpan Liu, Hanying Yi, Gan Zhou, Howard McLeod |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2025-06-01
|
| Series: | Journal for ImmunoTherapy of Cancer |
| Online Access: | https://jitc.bmj.com/content/13/6/e011611.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Periodontitis promotes tumor growth and immune evasion via PD-1/PD-L1
by: Suli Wang, et al.
Published: (2024-11-01) -
RIG-I promotes immune evasion of colon cancer by modulating PD-L1 ubiquitination
by: Jing Liu, et al.
Published: (2023-09-01) -
ASSOCIATION OF ADRB2 GENE POLYMORPHISM WITH MORPHOFUNCTIONAL ALTERATIONS IN PATIENTS WITH HYPERTROPHIC CARDIOMYPATHY
by: S. M. Komissarova, et al.
Published: (2012-06-01) -
Transcription Factor E2F1 Regulates the Expression of ADRB2
by: Juan Du, et al.
Published: (2023-01-01) -
PD-L2 glycosylation promotes immune evasion and predicts anti-EGFR efficacy
by: Min Li, et al.
Published: (2021-10-01)